ENDRA Life Sciences Inc.
NDRA· Nasdaq
NDRAENDRA Life Sciences Inc.
Filed Mar 26, 2020 · 10-K · 86 days after period end · 0001654954-20-003346
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $6.85K | — |
| Net Income | -$4.81M | -$2.37M | -$2.29M | -$688.88K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ENDRA Life Sciences Inc. · CIK 1681682 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 26, 2020 · 86 d after period end
